Intravenous Immunoglobulin Market Expected to Grow at 7.0% CAGR, Reaching USD 24.4 Billion by 2032
The Intravenous Immunoglobulin (IVIG) market is projected to experience significant growth, with market size increasing from USD 13.6 billion in 2022 to around USD 24.4 billion by 2032, registering a CAGR of 7.0% between 2023 and 2032. This growth can be attributed to several factors, including the rising prevalence of immunodeficiency diseases and an aging population that is more susceptible to such conditions. The increased adoption of IVIG for treating various neurological, dermatological, and inflammatory conditions also contributes to market expansion. Recent developments have seen advancements in plasma fractionation and recombinant technologies, enhancing the safety and efficacy of IVIG products.…
- Date: May 15, 2024
- Author: Robert Shaw
- Category: PharmiWeb